Lupkynis (voclosporin) - Aurinia Pharma
VOCAL: Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis (clinicaltrials.gov) - Jun 18, 2025 - P3 | N=40 | Recruiting | Sponsor: Aurinia Pharmaceuticals Inc. | Trial completion date: Jan 2025 ➔ Jun 2028 | Trial primary completion date: Dec 2024 ➔ Dec 2027 
Trial completion date • Trial primary completion date • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pediatrics
http://clinicaltrials.gov/ct2/show/NCT05288855
 
Jun 18, 2025
 
Prev Next